Pfizer (PFE) Total Liabilities (2016 - 2025)
Pfizer (PFE) has disclosed Total Liabilities for 17 consecutive years, with $121.4 billion as the latest value for Q4 2025.
- Quarterly Total Liabilities fell 2.81% to $121.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $121.4 billion through Dec 2025, down 2.81% year-over-year, with the annual reading at $121.4 billion for FY2025, 2.81% down from the prior year.
- Total Liabilities for Q4 2025 was $121.4 billion at Pfizer, up from $115.6 billion in the prior quarter.
- The five-year high for Total Liabilities was $137.2 billion in Q4 2023, with the low at $10.4 billion in Q4 2021.
- Average Total Liabilities over 5 years is $104.3 billion, with a median of $116.4 billion recorded in 2025.
- The sharpest move saw Total Liabilities dropped 12.14% in 2021, then skyrocketed 424.68% in 2023.
- Over 5 years, Total Liabilities stood at $104.0 billion in 2021, then decreased by 2.62% to $101.3 billion in 2022, then skyrocketed by 35.47% to $137.2 billion in 2023, then decreased by 8.97% to $124.9 billion in 2024, then dropped by 2.81% to $121.4 billion in 2025.
- According to Business Quant data, Total Liabilities over the past three periods came in at $121.4 billion, $115.6 billion, and $117.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.